Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» cholesterol
cholesterol
Novartis finalizes deal to make new heart drug widely available in England
BioPharma Dive
Wed, 09/1/21 - 10:55 pm
UK
Novartis
Leqvio
heart disease
cholesterol
What if a pill could lower cholesterol like pricey injectables? Esperion intends to find out
Stat
Wed, 01/13/21 - 10:36 am
Esperion Therapeutics
cholesterol
Serometrix
FDA Refuses to Approve Novartis' $9.7 Billion Cholesterol Drug for Now
Motley Fool
Sat, 12/19/20 - 11:41 pm
Novartis
FDA
cholesterol
inclisiran
complete response letter
Novartis’s big wager on RNAi approaches the finish line
EP Vantage
Wed, 11/25/20 - 10:27 am
Novartis
RNAi
COVID-19
Leqvio
cholesterol
Ionis and Akcea announce that Pfizer initiated clinical study of vupanorsen
Pharmaceutical Business Review
Wed, 11/4/20 - 10:13 am
Ionis Pharmaceuticals
Akcea Therapeutics
Pfizer
clinical trials
vupanorsen
cholesterol
AZ buys oral PCSK9 cholesterol drug from Dogma Therapeutics
Pharmaforum
Thu, 09/17/20 - 10:38 am
AstraZeneca
Dogma Therapeutics
cholesterol
PCSK9 inhibitors
ESC: Amgen chases pediatric use for cholesterol-busting PCSK9 med Repatha
Fierce Pharma
Sun, 08/30/20 - 11:25 pm
ESC
Amgen
Repatha
Sanofi
Regeneron
Praluent
cholesterol
In its first tough test, CRISPR base editing slashes cholesterol levels in monkeys
Stat
Sun, 06/28/20 - 07:10 pm
CRISPR
Verve Therapeutics
stem cells
cholesterol
Esperion strikes Japan deal for 'goldilocks' cholestrol drug, bags $60M cash as pandemic forces virtual US rollout
Endpoints
Mon, 04/20/20 - 10:37 am
Esperion
Nexletol
Nexlizet
Japan
cholesterol
Esperion adds more competition to cholesterol drug market with newly approved drug
BioPharma Dive
Fri, 02/21/20 - 11:57 pm
Esperion Therapeutics
cholesterol
bempedoic acid
FDA
Nexletol
Migraine, cholesterol upstarts top the list of FDA decisions to watch this quarter
Fierce Pharma
Fri, 01/3/20 - 11:03 pm
FDA
migraines
cholesterol
Epizyme
tazemetostat
Esperion
bempedoic acid
teprotumumab
Horizon Therapeutics
Biohaven
rimegepant
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
Xconomy
Wed, 09/25/19 - 11:53 am
The Medicines Company
clinical trials
inclisiran
cholesterol
Experion’s Cholesterol Drug Looks Great in Phase III, but Faces Tough Market
BioSpace
Tue, 03/19/19 - 11:30 am
Esperion
clinical trials
bempedoic acid
American College of Cardiology
cholesterol
Esperion’s cholesterol-lowering pill works when statins fail
Pharmaforum
Thu, 03/14/19 - 09:56 am
Esperion Therapeutics
cholesterol
statins
bempedoic acid
What's Next for Esperion Therapeutics' Cholesterol-Lowering Drug
Motley Fool
Thu, 11/8/18 - 09:42 am
Esperion Therapeutics
bempedoic acid
cholesterol
Esperion's Cholesterol Combo Pill Cuts Bad Cholesterol 35%
Forbes
Mon, 08/27/18 - 10:00 am
Esperion Therapeutics
bempedoic acid
statins
Zetia
Merck
cholesterol
Esperion bolsters cholesterol drug with new combo data
Biopharma Dive
Thu, 03/29/18 - 09:57 am
Esperion Therapeutics
bempedoic acid
cholesterol
Regeneron to Slash Price of Cholesterol Drug After Showing it Saved Lives
Xconomy
Sat, 03/10/18 - 09:12 am
Regeneron
cholesterol
drug pricing
Sanofi
Praluent
Esperion's cholesterol drug succeeds in late-stage study
Reuters
Thu, 03/8/18 - 09:41 am
Esperion Therapeutics
clinical trials
bempedoic acid
cholesterol
The Moment Of Truth Is Coming For Struggling And Expensive Cholesterol Drugs
Forbes
Sun, 02/18/18 - 10:16 am
cholesterol
PCSK9 inhibitors
Sanofi
Regeneron
Praluent
Amgen
Repatha
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »